Alterity Therapeutics: Receives U.S. patent for neurodegenerative diseases
Alterity Therapeutics (ATH) has received a U.S. patent to trial treatments for neurodegenerative diseases, such as Alzheimer's and Parkinson diseases
The patent covers...
© 2026 FintechInshorts. All Rights Reserved.

